Noninvasive Imaging of Natural Killer Cell-Mediated Apoptosis in a Mouse Tumor Model

Thoudam Debraj Singh1, Jaetae Lee2,3, Yong Hyun Jeon4,5

  • 1Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, South Korea.

Insights

Natural killer (NK) cells fight cancer by triggering apoptosis. This study introduces a new bioluminescence imaging method to track NK cell therapy

Area of Science:

  • Immunology
  • Oncology
  • Biomedical Imaging

Background:

  • Natural killer (NK) cells are crucial cytotoxic lymphocytes.
  • NK cells induce apoptosis in cancer cells via a caspase-3-dependent pathway.
  • Effective NK cell immunotherapy necessitates sensitive in vivo monitoring tools.

Purpose of the Study:

  • To develop and validate a noninvasive bioluminescence imaging (BLI) approach.
  • To monitor the dynamic events of caspase-3-dependent apoptosis in vivo.
  • To assess the antitumor effects of NK cell-based therapy for human glioma.

Main Methods:

  • Utilized a mouse model of human glioma.
  • Employed serial bioluminescence imaging.
  • Focused on tracking caspase-3-dependent apoptosis as a readout.

Main Results:

  • Demonstrated the feasibility of noninvasive in vivo imaging of apoptosis.
  • Successfully monitored the antitumor effects of NK cell therapy.
  • Provided a dynamic visualization of therapeutic response.

Conclusions:

  • Noninvasive BLI is a powerful tool for evaluating NK cell therapy.
  • This method allows for real-time assessment of apoptosis-induced tumor regression.
  • The approach holds promise for optimizing cancer immunotherapy strategies.

Related Concept Videos